Open AccessSwitching to Once-Daily Liraglutide From Twice-Daily Exenatide Further Improves Glycemic Control in Patients With Type 2 Diabetes Using Oral Agents
Author(s) -
J. B. Buse,
Georgio Sesti,
W. E. Schmidt,
E. Montanya,
C.-T. Chang,
Yilin Xu,
Laurent Blondé,
J. Rosenstock
Publication year - 2010
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/bnt5-cj47
Subject(s) - liraglutide , exenatide , glycemic , type 2 diabetes , medicine , diabetes mellitus , glucagon like peptide 1 , endocrinology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom